Cognyte Software (CGNT) Stock Chart & Stock Price History → Fidelity, Bezos, Goldman Bet Big on Tiny Biotech (From Behind the Markets) (Ad) Free CGNT Stock Alerts $7.63 -0.02 (-0.26%) (As of 05/8/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Cognyte Software Stock Price Performance5 Day Performance+4.81%1 Month Performance-9.27%3 Month Performance+2.14%6 Month Performance+77.44%Year-To-Date Performance+18.66%1 Year Performance+77.44% Receive CGNT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cognyte Software and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Crypto 101 MediaTech GIANT’s Plans to Revolutionize Crypto…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. CGNT Stock Chart for Wednesday, May, 8, 2024 CGNT Chart by TradingView Cognyte Software Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/07/2024$7.50$7.65+2.00%$7.68$7.46438,549 shs$543.30 million05/06/2024$7.28$7.50+3.02%$7.52$7.30209,649 shs$532.65 million05/03/2024$7.00$7.28+4.00%$7.36$7.03233,887 shs$517.05 million05/02/2024$6.83$7.00+2.49%$7.04$6.87232,014 shs$497.14 million05/01/2024$6.82$6.83+0.15%$7.01$6.77232,552 shs$485.07 million04/30/2024$6.91$6.82-1.30%$6.86$6.73190,478 shs$484.36 million Get the Latest News and Ratings for CGNT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cognyte Software and its competitors with MarketBeat's FREE daily newsletter. 04/29/2024$6.90$6.91+0.14%$7.01$6.87191,281 shs$490.75 million04/26/2024$6.86$6.90+0.58%$6.95$6.83206,402 shs$490.04 million04/25/2024$6.93$6.86-1.01%$6.96$6.76175,470 shs$487.20 million04/24/2024$6.81$6.93+1.76%$6.97$6.72262,797 shs$492.17 million04/23/2024$6.64$6.81+2.56%$6.94$6.68252,263 shs$483.65 million04/22/2024$6.42$6.64+3.43%$6.65$6.36349,207 shs$471.57 million04/19/2024$6.54$6.42-1.83%$6.59$6.42425,303 shs$455.97 million04/18/2024$6.64$6.54-1.51%$6.74$6.51293,256 shs$464.47 million04/17/2024$6.71$6.64-1.04%$6.78$6.54476,611 shs$471.57 million04/16/2024$6.62$6.71+1.36%$6.78$6.51340,258 shs$476.54 million04/15/2024$6.73$6.62-1.63%$6.81$6.56401,331 shs$470.15 million04/12/2024$7.02$6.73-4.13%$6.98$6.60481,000 shs$477.97 million04/11/2024$6.97$7.02+0.72%$7.17$6.81593,107 shs$483.26 million04/10/2024$7.27$6.97-4.13%$7.18$6.89788,792 shs$479.82 million04/09/2024$8.41$7.27-13.56%$7.94$6.802.53 million shs$500.47 million04/08/2024$8.14$8.41+3.32%$8.49$8.27461,433 shs$578.94 million04/05/2024$8.20$8.14-0.73%$8.26$8.10230,028 shs$560.38 million04/04/2024$8.30$8.20-1.20%$8.40$8.19248,470 shs$564.49 million04/03/2024$8.18$8.30+1.47%$8.41$8.16196,509 shs$571.37 million04/02/2024$8.26$8.18-0.91%$8.21$8.03177,910 shs$563.11 million04/01/2024$8.27$8.26-0.18%$8.53$8.20202,198 shs$568.27 million03/29/2024$8.27$8.27$8.30$7.95274,171 shs$569.31 million03/28/2024$8.01$8.27+3.25%$8.30$7.95273,770 shs$569.31 million03/27/2024$7.85$8.01+2.04%$8.02$7.79211,074 shs$551.41 million03/26/2024$7.93$7.85-1.01%$7.97$7.76174,853 shs$540.39 million03/25/2024$7.88$7.93+0.63%$8.09$7.91209,993 shs$545.90 million03/22/2024$7.78$7.88+1.35%$7.95$7.63214,277 shs$542.46 million03/21/2024$7.91$7.78-1.71%$8.05$7.76198,025 shs$535.23 million03/20/2024$7.66$7.91+3.26%$7.93$7.59146,859 shs$544.55 million03/19/2024$7.79$7.66-1.67%$7.76$7.53183,419 shs$527.31 million03/18/2024$7.62$7.79+2.23%$8.03$7.66210,165 shs$536.26 million03/15/2024$7.67$7.62-0.65%$7.67$7.42475,985 shs$524.58 million03/14/2024$8.04$7.67-4.60%$8.22$7.63294,406 shs$528.00 million03/13/2024$7.35$8.04+9.39%$8.18$7.42600,004 shs$553.47 millionCould this Tiny Biotech End Disease Forever? (Ad)Imagine a revolutionary treatment capable of editing out ANY disease. By literally "cutting" the genetic instructions that cause illness, and "pasting" in corrected DNA to restore perfect health.Access my full "Cut & Paste" profit analysis now.03/12/2024$7.26$7.35+1.24%$7.37$7.18181,658 shs$505.97 million03/11/2024$7.30$7.26-0.55%$7.31$7.20195,279 shs$499.78 million03/08/2024$7.36$7.30-0.82%$7.41$7.12184,682 shs$502.53 million03/07/2024$7.34$7.36+0.27%$7.37$7.19235,560 shs$506.66 million03/06/2024$7.35$7.34-0.14%$7.48$7.12270,154 shs$505.31 million03/05/2024$7.43$7.35-1.08%$7.41$7.20265,240 shs$505.97 million03/04/2024$7.57$7.43-1.85%$7.62$7.41158,147 shs$511.48 million03/01/2024$7.42$7.57+2.02%$7.64$7.32241,481 shs$521.14 million02/29/2024$7.36$7.42+0.82%$7.50$7.32223,288 shs$510.79 million02/28/2024$7.42$7.36-0.81%$7.44$7.35169,754 shs$506.66 million02/27/2024$7.42$7.42$7.50$7.31170,762 shs$510.79 million02/26/2024$7.26$7.42+2.20%$7.50$7.27209,495 shs$510.79 million02/23/2024$7.30$7.26-0.55%$7.30$7.13288,866 shs$499.78 million02/22/2024$7.20$7.30+1.39%$7.35$7.21188,419 shs$502.53 million02/21/2024$7.47$7.20-3.61%$7.38$7.03476,082 shs$495.67 million02/20/2024$7.49$7.47-0.27%$7.54$7.40331,215 shs$514.24 million02/19/2024$7.49$7.49$7.65$7.43301,900 shs$515.61 million02/16/2024$7.66$7.49-2.22%$7.65$7.43301,698 shs$515.61 million02/15/2024$7.50$7.66+2.13%$7.78$7.55388,363 shs$527.31 million02/14/2024$7.31$7.50+2.60%$7.50$7.32251,950 shs$516.30 million02/13/2024$7.51$7.31-2.66%$7.42$7.06454,487 shs$503.22 million02/12/2024$7.48$7.51+0.40%$7.59$7.37262,592 shs$516.99 million02/09/2024$7.47$7.48+0.13%$7.51$7.35272,570 shs$514.92 million02/08/2024$7.40$7.47+0.95%$7.50$7.25294,434 shs$514.24 million02/07/2024$7.24$7.40+2.21%$7.57$7.03485,018 shs$509.42 million Related Companies: Bandwidth Stock Chart CS Disco Stock Chart 3D Systems Stock Chart SecureWorks Stock Chart BigBear.ai Stock Chart Magic Software Enterprises Stock Chart Backblaze Stock Chart Cerence Stock Chart MiX Telematics Stock Chart American Software Stock Chart Receive CGNT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Cognyte Software and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CGNT) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaAI “wealth window” is closing June 25thParadigm PressGold Set to EXPLODE!Gold Safe ExchangeCharles Payne Demystifies OptionsUnstoppable ProsperityThe AI Stock that’s Disrupting Every IndustryStockEarningsShocking: One AI startup's revenue could surge 4,735%Manward PressThe 2024 Gold Rush: Unleashing Market PotentialPriority Gold Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cognyte Software Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.